PT Kalbe Farma Tbk. (IDX:KLBF)

Market Cap	44.38T -11.0%
Revenue (ttm)	35.32T +8.3%
Net Income	3.66T +13.1%
EPS	80.51 +14.7%
Shares Out	45.29B
PE Ratio	12.17
Forward PE	12.50
Dividend	36.00 (3.67%)
Ex-Dividend Date	Jun 4, 2025

Volume	7,186,200
Average Volume	34,428,540
Open	985.00
Previous Close	980.00
Day's Range	980.00 - 995.00
52-Week Range	935.00 - 1,600.00
Beta	0.11
RSI	48.66
Earnings Date	Apr 29, 2026

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1966
• Employees: 12,835
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: KLBF

Financial Performance

In 2025, PT Kalbe Farma Tbk.'s revenue was 35.32 trillion, an increase of 8.27% compared to the previous year's 32.63 trillion. Earnings were 3.66 trillion, an increase of 13.09%.